244 related articles for article (PubMed ID: 21806614)
1. High doses of amphetamine augment, rather than disrupt, exocytotic dopamine release in the dorsal and ventral striatum of the anesthetized rat.
Ramsson ES; Howard CD; Covey DP; Garris PA
J Neurochem; 2011 Dec; 119(6):1162-72. PubMed ID: 21806614
[TBL] [Abstract][Full Text] [Related]
2. Amphetamine augments action potential-dependent dopaminergic signaling in the striatum in vivo.
Ramsson ES; Covey DP; Daberkow DP; Litherland MT; Juliano SA; Garris PA
J Neurochem; 2011 Jun; 117(6):937-48. PubMed ID: 21443523
[TBL] [Abstract][Full Text] [Related]
3. Amphetamine paradoxically augments exocytotic dopamine release and phasic dopamine signals.
Daberkow DP; Brown HD; Bunner KD; Kraniotis SA; Doellman MA; Ragozzino ME; Garris PA; Roitman MF
J Neurosci; 2013 Jan; 33(2):452-63. PubMed ID: 23303926
[TBL] [Abstract][Full Text] [Related]
4. Amphetamine augments vesicular dopamine release in the dorsal and ventral striatum through different mechanisms.
Avelar AJ; Juliano SA; Garris PA
J Neurochem; 2013 May; 125(3):373-85. PubMed ID: 23406303
[TBL] [Abstract][Full Text] [Related]
5. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA
J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422
[TBL] [Abstract][Full Text] [Related]
6. G protein-coupled receptor signaling in VTA dopaminergic neurons bidirectionally regulates the acute locomotor response to amphetamine but does not affect behavioral sensitization.
Runegaard AH; Dencker D; Wörtwein G; Gether U
Neuropharmacology; 2019 Dec; 161():107663. PubMed ID: 31173760
[TBL] [Abstract][Full Text] [Related]
7. Membrane-permeable C-terminal dopamine transporter peptides attenuate amphetamine-evoked dopamine release.
Rickhag M; Owens WA; Winkler MT; Strandfelt KN; Rathje M; Sørensen G; Andresen B; Madsen KL; Jørgensen TN; Wörtwein G; Woldbye DPD; Sitte H; Daws LC; Gether U
J Biol Chem; 2013 Sep; 288(38):27534-27544. PubMed ID: 23884410
[TBL] [Abstract][Full Text] [Related]
8. Amphetamine elicits opposing actions on readily releasable and reserve pools for dopamine.
Covey DP; Juliano SA; Garris PA
PLoS One; 2013; 8(5):e60763. PubMed ID: 23671560
[TBL] [Abstract][Full Text] [Related]
9. Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine.
Williams JM; Owens WA; Turner GH; Saunders C; Dipace C; Blakely RD; France CP; Gore JC; Daws LC; Avison MJ; Galli A
PLoS Biol; 2007 Oct; 5(10):e274. PubMed ID: 17941718
[TBL] [Abstract][Full Text] [Related]
10. Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores.
Schmitz Y; Lee CJ; Schmauss C; Gonon F; Sulzer D
J Neurosci; 2001 Aug; 21(16):5916-24. PubMed ID: 11487614
[TBL] [Abstract][Full Text] [Related]
11. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores.
Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1986 Apr; 237(1):193-203. PubMed ID: 3007738
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter.
Jones SR; Gainetdinov RR; Wightman RM; Caron MG
J Neurosci; 1998 Mar; 18(6):1979-86. PubMed ID: 9482784
[TBL] [Abstract][Full Text] [Related]
13. Biphasic mechanisms of amphetamine action at the dopamine terminal.
Siciliano CA; Calipari ES; Ferris MJ; Jones SR
J Neurosci; 2014 Apr; 34(16):5575-82. PubMed ID: 24741047
[TBL] [Abstract][Full Text] [Related]
14. Difference in magnitude of psychostimulant-induced extracellular norepinephrine in the ventral tegmental area contributes to discrepant prefrontal dopamine outflow.
Pan WH; Hsieh MC; Wu HH; Lin SK
Addict Biol; 2007 Mar; 12(1):51-8. PubMed ID: 17407497
[TBL] [Abstract][Full Text] [Related]
15. Amphetamine-induced reverse transport of dopamine does not require cytosolic Ca
Støier JF; Konomi-Pilkati A; Apuschkin M; Herborg F; Gether U
J Biol Chem; 2023 Aug; 299(8):105063. PubMed ID: 37468107
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Dopamine Release by Dopamine Transport Inhibitors Described by a Restricted Diffusion Model and Fast-Scan Cyclic Voltammetry.
Hoffman AF; Spivak CE; Lupica CR
ACS Chem Neurosci; 2016 Jun; 7(6):700-9. PubMed ID: 27018734
[TBL] [Abstract][Full Text] [Related]
17. Effects of the administration of amphetamine, either alone or in combination with reserpine or cocaine, on regional brain beta-phenylethylamine and dopamine release.
Karoum F; Wolf ME; Mosnaim AD
Am J Ther; 1997; 4(9-10):333-42. PubMed ID: 10423628
[TBL] [Abstract][Full Text] [Related]
18. Amphetamine elevates nucleus accumbens dopamine via an action potential-dependent mechanism that is modulated by endocannabinoids.
Covey DP; Bunner KD; Schuweiler DR; Cheer JF; Garris PA
Eur J Neurosci; 2016 Jun; 43(12):1661-73. PubMed ID: 27038339
[TBL] [Abstract][Full Text] [Related]
19. Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex.
Berridge CW; Stalnaker TA
Synapse; 2002 Dec; 46(3):140-9. PubMed ID: 12325041
[TBL] [Abstract][Full Text] [Related]
20. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
